CDNACaredx Inc
$26.18
$2.70
(11.50%)
Closed $26.18
$0.02
(0.08%)
After Hours
EarningsAug 5
Mkt Cap$1.35B
Vol2.74M
Fundamentals
CareDx Reaches Analyst Target Price
In recent trading, shares of CareDx Inc (Symbol: CDNA) have crossed above the average analyst 12-month target price of $25.80, changing hands for $26.18/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation...
Nasdaq News: Markets
CareDx (CDNA) Moves 11.5% Higher: Will This Strength Last?
CareDx (CDNA) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Zacks
CareDx Precision Medicine Diagnostics Showcased in Over 30 Abstracts and 9 Oral Presentations at the 2026 American Transplant Congress
CareDx, Inc. (Nasdaq: CDNA) The Transplant Company, a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, highvalue healthcare solutions for transplant patients and caregivers, today announced its participation at the...
Business Wire
CareDx Announces Second KOAR Analysis Published in the Journal of the American Society of Nephrology
CareDx, Inc. (Nasdaq: CDNA) The Transplant Company, a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, highvalue healthcare solutions for transplant patients and caregivers, today announced the publication of a new...
Business Wire
CareDx to Participate in Upcoming Investor Conferences
CareDx, Inc. (Nasdaq: CDNA) The Transplant Company, a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, highvalue healthcare solutions for transplant patients and caregivers, today announced the company will participate in...
Business Wire
CareDx Announces Dismissal of 2021 Qui Tam Suit
CareDx, Inc. (Nasdaq: CDNA) The Transplant Company, a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value...
Business Wire
CareDx (NASDAQ:CDNA) Upgraded to Strong-Buy at Wall Street Zen
Wall Street Zen raised shares of CareDx from a "buy" rating to a "strong-buy" rating in a research note on Sunday...
MarketBeat
CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CareDx, Inc. (Nasdaq: CDNA), The Transplant Company a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value...
Business Wire
CareDx (NASDAQ:CDNA) Trading Down 8.7% - What's Next?
CareDx (NASDAQ:CDNA) Trading Down 8.7% - Here's What Happened...
MarketBeat
CareDx Q1 Earnings Call Highlights
CareDx (NASDAQ:CDNA) reported first-quarter 2026 results showing faster growth in its core testing and patient services businesses, while outlining two major portfolio moves: the pending divestiture...
MarketBeat
<
1
2
...
>